Riscoe; Michael K.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Riscoe; Michael K..The latest application filed is for "robenidine analogs as potent antimalarials against drug-resistant plasmodium falciparum".
- Riscoe; Michael K. - Portland OR
- Riscoe; Michael K. - Tualatin OR
| Patent | Date |
|---|---|
| Robenidine Analogs As Potent Antimalarials Against Drug-resistant Plasmodium Falciparum App 20220267258 - Krollenbrock; Alina ; et al. | 2022-08-25 |
| Alkoxycarbonate Ester Prodrugs For Use As Antimalarial Agents App 20200369616 - Riscoe; Michael K. ; et al. | 2020-11-26 |
| Compounds, compositions and associated methods comprising 3-aryl quinolines Grant 10,023,538 - Riscoe , et al. July 17, 2 | 2018-07-17 |
| Compounds, Compositions And Associated Methods Comprising 3-aryl Quinolines App 20180009760 - Riscoe; Michael K. ; et al. | 2018-01-11 |
| Acridone Compounds App 20170144974 - Riscoe; Michael K. ; et al. | 2017-05-25 |
| Compounds, Compositions And Associated Methods Comprising 3-aryl Quinolines App 20160340313 - Riscoe; Michael K. ; et al. | 2016-11-24 |
| Acridone compounds Grant 9,399,625 - Riscoe , et al. July 26, 2 | 2016-07-26 |
| Compounds, compositions and associated methods comprising 3-aryl quinolines Grant 9,249,103 - Riscoe , et al. February 2, 2 | 2016-02-02 |
| Compounds having antiparasitic or anti-infectious activity Grant 9,206,131 - Riscoe , et al. December 8, 2 | 2015-12-08 |
| Acridone Compounds App 20150210645 - Riscoe; Michael K. ; et al. | 2015-07-30 |
| Acridone compounds Grant 8,987,296 - Riscoe , et al. March 24, 2 | 2015-03-24 |
| Compounds, Compositions And Associated Methods Comprising 3-aryl Quinolines App 20140350048 - Riscoe; Michael K. ; et al. | 2014-11-27 |
| Acridone Compounds App 20140128423 - Riscoe; Michael K. ; et al. | 2014-05-08 |
| Compounds Having Antiparasitic Or Anti-infectious Activity App 20140045888 - Riscoe; Michael K. ; et al. | 2014-02-13 |
| Compounds having antiparasitic or anti-infectious activity Grant 8,598,354 - Riscoe , et al. December 3, 2 | 2013-12-03 |
| Acridone compounds Grant 8,592,447 - Riscoe , et al. November 26, 2 | 2013-11-26 |
| Compounds for treating parasitic disease Grant 8,481,543 - Riscoe , et al. July 9, 2 | 2013-07-09 |
| Compounds Having Antiparasitic Or Anti-infectious Activity App 20120115904 - Riscoe; Michael K. ; et al. | 2012-05-10 |
| Compounds Having Antiparasitic Or Anti-infectious Activity App 20120010237 - Riscoe; Michael K. ; et al. | 2012-01-12 |
| Compounds For Treating Parasitic Disease App 20110251209 - Riscoe; Michael K. ; et al. | 2011-10-13 |
| Aromatic ketones and uses thereof Grant 7,829,578 - Riscoe , et al. November 9, 2 | 2010-11-09 |
| Acridone Compounds App 20100069428 - Riscoe; Michael K. ; et al. | 2010-03-18 |
| Xanthone analogs for treating infectious diseases and complexation of heme and porphyrins Grant 6,613,797 - Winter , et al. September 2, 2 | 2003-09-02 |
| Xanthone analogs for treating infectious diseases and complexation of heme and porphyrins App 20020055644 - Winter, Rolf W. ; et al. | 2002-05-09 |
| Methylthioribose analogs, their preparation and use as medicinal agents and biocides Grant 4,820,692 - Riscoe , et al. April 11, 1 | 1989-04-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 